Evaluation of Molecular Breast Imaging in Patients With a High Likelihood of Ductal Carcinoma in Situ

Trial Information

Evaluation of Molecular Breast Imaging in Patients With a High Likelihood of Ductal Carcinoma in Situ

Patients who are suspected to have DCIS based on mammographic findings will be invited to
participate in this study. The investigators plan to recruit 200 patients who are scheduled
to undergo a breast biopsy for a breast lesion considered suggestive or highly suggestive of
DCIS as determined by a radiologist specializing in breast imaging. Each patient will have
a suspicious area of calcification on mammography of extent < 3 cm, or a non-focal area of
abnormality on ultrasound or MRI that is scheduled for evaluation by biopsy. Each patient
will undergo an MBI study immediately prior to biopsy. The study coordinator will approach
these patients and inform them of the research project. If they are interested in
participating, informed consent will be obtained and the patient will be scheduled for the
MBI study prior to the breast biopsy.